Retatrutide (GLP-3R)
Retatrutide is a triple GLP-1/GIP/Glucagon receptor agonist with the highest recorded weight loss results in any peptide trial.
Research Reference Compound
For laboratory and educational research purposes only.
*Strictly for laboratory research purposes.
Purity
99%+
Batch ID
PV-2026
Testing Date
JAN 2026
Form
Lyophilized
Research Overview
Retatrutide is a triple GLP-1/GIP/Glucagon receptor agonist with the highest recorded weight loss results in any peptide trial.
All PepVive compounds are laboratory research peptides manufactured to the highest standards, third-party HPLC tested, and verified for USA. This product is intended strictly for in-vitro and laboratory research purposes.
Key Research Areas
- Triple Agonist Mechanisms: Simultaneous GLP-1, GIP, and glucagon receptor activation.
- Unprecedented Weight Loss: 24.2% mean body weight reduction — highest in any metabolic peptide trial.
- Cardiovascular Research: Visceral fat, liver fat, and cardiometabolic marker reduction.
- Energy Expenditure: Glucagon receptor contribution to increased thermogenesis.
Quality Standards
- Third-party HPLC tested for purity
- Lyophilized for maximum stability
- Vacuum sealed for long-term storage
Technical Specs
Researcher Feedback
"Exceptional purity levels. HPLC reports matched our internal testing exactly."
"Secure packaging and consistent quality. The lyophilized form is highly stable."
"Best source for research compounds. Consistency across batches is impressive."